You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

aflibercept

Showing 1 - 25 of 125
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chorioretinal Vascular Disease Trial (ABP 938, Aflibercept)

Not yet recruiting
  • Chorioretinal Vascular Disease
  • ABP 938
  • Aflibercept
  • (no location specified)
Jan 20, 2023

Aflibercept for Diabetic Macular Edema In Real-life Practice in

Completed
  • Diabetic Macular Edema
  • Aflibercept
  • Athens, Greece
    University of Athens
Dec 27, 2022

Diabetic Macular Edema, Pars Plana Vitrectomy, Dexamethasone Intravitreal Implant Trial in Tianjin (Ozurdex, Aflibercept)

Not yet recruiting
  • Diabetic Macular Edema
  • +3 more
  • Tianjin, Tianjin, China
    Tianjin medical university eye hosipital
Aug 6, 2023

Wet Age-related Macular Degeneration Trial in Beijing (RC28-E, Aflibercept)

Recruiting
  • Wet Age-related Macular Degeneration
  • Beijing, Beijing, China
    Beijing Hospital
Feb 3, 2023

Metastatic Colorectal Cancer Trial in Madrid (Aflibercept, Irinotecan, folinic acid (dl racemic))

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Aflibercept
  • +4 more
  • Madrid, Spain
    Spanish Cooperative Group for Digestive Tumour Therapy (TTD)
Oct 10, 2022

rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen

Completed
  • Age Related Macular Degeneration
  • Aflibercept
  • Bern, Switzerland
  • +1 more
Nov 28, 2022

Wet Age-related Macular Degeneration Trial in Bern (Aflibercept, Brolucizumab, early treat and extend (T&E))

Enrolling by invitation
  • Wet Age-related Macular Degeneration
  • Aflibercept
  • +2 more
  • Bern, Switzerland
    Berner Augenklinik am Lindenhofspital
May 13, 2022

Neovascular Glaucoma Trial in Aurora (Aflibercept)

Completed
Has Results
  • Neovascular Glaucoma
  • Aflibercept
  • Aurora, Colorado
    Rocky Mountain Lions Eye Institute
Feb 16, 2022

Neovascular Age-Related Macular Degeneration Trial in Worldwide (Ranibizumab, Aflibercept, Port Delivery System with ranibizumab

Suspended
  • Neovascular Age-Related Macular Degeneration
  • Capital Federal, Argentina
  • +9 more
Nov 8, 2022

Non-Ischemic Central Retinal Vein Occlusion With Macular Edema Trial in Qina (intravitreal injection of Ranibizumab,

Recruiting
  • Non-Ischemic Central Retinal Vein Occlusion With Macular Edema
  • intravitreal injection of Ranibizumab
  • +3 more
  • Qinā, Qena, Egypt
    Ahmed Ali Ahmed Amer
Mar 15, 2022

Diabetic Macular Edema Trial in China (Brolucizumab, Aflibercept)

Active, not recruiting
  • Diabetic Macular Edema
  • Guangzhou, Guangdong, China
  • +23 more
Jan 20, 2023

Age-Related Macular Degeneration Trial in Hong Kong (Brolucizumab, Aflibercept)

Recruiting
  • Age-Related Macular Degeneration
  • Hong Kong, Hong Kong
    Grantham Hospital
Jan 25, 2023

Neovascular Age-related Macular Degeneration Trial in Phoenix (CLS-AX, Aflibercept)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Phoenix, Arizona
    Retinal Research Institute, LLC
Jun 4, 2023

Diabetic Macular Edema Trial in Beijing (9MW0813, Aflibercept)

Recruiting
  • Diabetic Macular Edema
  • Beijing, Beijing, China
    Beijing tongren hospital affliated to capital medical university
Apr 5, 2022

Diabetic Macular Edema Trial in Beijing (9MW0813, Aflibercept)

Completed
  • Diabetic Macular Edema
  • Beijing, Beijing, China
    Beijing tongren hospital affliated to capital medical university
Apr 5, 2022

Neovascular Age-related Macular Degeneration Trial in Worldwide (AKST4290, Placebo, Aflibercept)

Completed
Has Results
  • Neovascular Age-related Macular Degeneration
  • Beverly Hills, California
  • +20 more
Oct 24, 2022

Wet Age-related Macular Degeneration Trial in Beijing (Aflibercept)

Completed
  • Wet Age-related Macular Degeneration
  • Aflibercept
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Apr 19, 2022

Diabetic Macular Edema, Retinal Disease, Macular Edema Trial in United States (Aflibercept, foselutoclax)

Not yet recruiting
  • Diabetic Macular Edema
  • +8 more
  • Bakersfield, California
  • +7 more
Aug 23, 2023

Wet Age-related Macular Degeneration Trial (SCB-420, Aflibercept)

Withdrawn
  • Wet Age-related Macular Degeneration
  • (no location specified)
Apr 12, 2022

Neovascular Age-related Macular Degeneration Trial in Suzhou (Low dose IBI302, High dose IBI302, Aflibercept)

Active, not recruiting
  • Neovascular Age-related Macular Degeneration
  • Low dose IBI302
  • +2 more
  • Suzhou, Jiangsu, China
    Innovent Biologics (Suzhou) Co,Ltd.
Sep 12, 2022

Neovascular Age-related Macular Degeneration Trial (dose 1 IBI302, Aflibercept, dose 2 IBI302)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • dose 1 IBI302
  • +2 more
  • (no location specified)
May 26, 2022

Adverse Effect of Radiation Therapy Trial (aflibercept)

Completed
Has Results
  • Adverse Effect of Radiation Therapy
  • aflibercept
  • (no location specified)
Apr 17, 2021

Age Related Macular Degeneration Trial in London (Ranibizumab, Aflibercept)

Completed
  • Age Related Macular Degeneration
  • London, UK, United Kingdom
    King's College Hospital NHS Foundation Trust
Apr 29, 2021

Diabetes, Diabetic Retinopathy, Diabetic Macular Edema Trial in Worldwide (THR-687 dose level 1, THR-687 dose level 2, THR-687

Terminated
  • Diabetes Mellitus
  • +2 more
  • THR-687 dose level 1
  • +3 more
  • Huntington Beach, California
  • +24 more
Jul 19, 2022

Diabetic Macular Edema Trial in Houston (Dexamethasone implant, Aflibercept)

Recruiting
  • Diabetic Macular Edema
  • Dexamethasone implant
  • Aflibercept
  • Houston, Texas
    Retina Consultants of Houston
Jul 19, 2021